deferoxamine has been researched along with Kaposi Sarcoma in 6 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simonart, T | 5 |
| Boelaert, JR | 4 |
| Andrei, G | 3 |
| van den Oord, JJ | 1 |
| Degraef, C | 2 |
| Hermans, P | 3 |
| Noel, JC | 3 |
| Van Vooren, JP | 4 |
| Heenen, M | 3 |
| De Clercq, E | 1 |
| Snoeck, R | 3 |
| Parent, D | 1 |
| Lunardi-Yskandar, Y | 1 |
| Lambert, C | 1 |
| Dieye, T | 1 |
| Farber, CM | 1 |
| Liesnard, C | 1 |
| Mallery, SR | 1 |
| Clark, YM | 1 |
| Ness, GM | 1 |
| Minshawi, OM | 1 |
| Pei, P | 1 |
| Hohl, CM | 1 |
| Mosselmans, R | 1 |
6 other studies available for deferoxamine and Kaposi Sarcoma
| Article | Year |
|---|---|
Desferrioxamine enhances AIDS-associated Kaposi's sarcoma tumor development in a xenograft model.
Topics: Acquired Immunodeficiency Syndrome; Animals; Apoptosis; Body Weight; Bromodeoxyuridine; Cell Divisio | 2002 |
Iron: a target for the management of Kaposi's sarcoma?
Topics: Africa; Deferiprone; Deferoxamine; Female; Herpesvirus 8, Human; Humans; Iron Chelating Agents; Iron | 2004 |
Iron as a potential co-factor in the pathogenesis of Kaposi's sarcoma?
Topics: Carcinogens; Cell Division; Chelating Agents; Chlorides; Deferoxamine; Ferric Compounds; Fibroblast | 1998 |
Thiol redox modulation of doxorubicin mediated cytotoxicity in cultured AIDS-related Kaposi's sarcoma cells.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Apoptosis; Deferoxamine; DNA Rep | 1999 |
Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors.
Topics: Apoptosis; Cell Culture Techniques; Deferoxamine; Endothelium, Vascular; Humans; Iron; Iron Chelatin | 2000 |
Enhancement of classic Kaposi's sarcoma growth after intralesional injections of desferrioxamine.
Topics: Aged; Aged, 80 and over; Apoptosis; Deferoxamine; Humans; Injections, Intralesional; Iron Chelating | 2002 |